awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q55195946-7EA70178-F873-427B-80A4-2B435E783700
Q55195946-7EA70178-F873-427B-80A4-2B435E783700
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55195946-7EA70178-F873-427B-80A4-2B435E783700
Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study.
P2860
Q55195946-7EA70178-F873-427B-80A4-2B435E783700
BestRank
Statement
http://www.wikidata.org/entity/statement/Q55195946-7EA70178-F873-427B-80A4-2B435E783700
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
907812f32d862a44fa01d7b08c6e693b257fdb4b
P2860
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.